IDH1 and glioblastoma: To be more particularly, the mutational frequencies of IDH1 in LGG patients were 78%, 77%, 61%, and in GBM patients were 4%, 5%, 5% in our cohort, TCGA cohort, and CGGA cohort, respectively (Supplementary Fig. 2K).